M-40401

N/A

Report date: 2022/08/23 20:00:44
NME

Base Information

Drug NameM-40401
Drug Alias NameM40401
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSuperoxide dismutase stimulants
TargetsSuperoxide dismutase
Therapy Area/IndicationsReperfusion InjuryNervous System DiseasesHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesJapan
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMetaphore Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsReperfusion InjuryNervous System DiseasesHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A